[{"abstract": "Jeffrey B. Kindler\u2019s retirement comes almost two years after he led Pfizer\u2019s bid for Wyeth, the first major deal after the financial crisis.", "web_url": "https://dealbook.nytimes.com/2010/12/05/pfizers-chief-architect-of-its-mega-merger-retires/", "snippet": "Jeffrey B. Kindler\u2019s retirement comes almost two years after he led Pfizer\u2019s bid for Wyeth, the first major deal after the financial crisis.", "lead_paragraph": "Jeffrey B. Kindler announcing Pfizer\u2019s $68 billion deal for Wyeth in January 2009.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Pfizer Loses Man Behind Wyeth Deal", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "persons", "value": "Kindler, Jeffrey B", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 2, "major": "N"}], "pub_date": "2010-12-06T01:50:56+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Michael J. de la Merced", "person": [{"firstname": "Michael", "middlename": "J.", "lastname": "de la Merced", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/d3a1f39e-25a5-5f20-9106-0cc9ae69f012", "word_count": 405, "uri": "nyt://article/d3a1f39e-25a5-5f20-9106-0cc9ae69f012"}, {"abstract": "Jeffrey Kindler will be succeeded as chief executive by Ian Read, and the board will vote on a new chairman within two weeks.", "web_url": "https://www.nytimes.com/2010/12/06/business/06drug.html", "snippet": "Jeffrey Kindler will be succeeded as chief executive by Ian Read, and the board will vote on a new chairman within two weeks.", "lead_paragraph": "Jeffrey B. Kindler is retiring as chief executive and chairman of Pfizer, the world\u2019s largest pharmaceutical firm, the company said on Sunday evening in an unexpected announcement.", "print_section": "B", "print_page": "2", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2010/12/06/business/drug/drug-jumbo.jpg", "height": 1024, "width": 815, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2010/12/06/business/drug/drug-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2010/12/06/business/drug/drug-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}], "headline": {"main": "Pfizer\u2019s Chairman and Chief Retires Unexpectedly", "kicker": null, "content_kicker": null, "print_headline": "Pfizer&#8217;s Chairman and Chief Retires Unexpectedly", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Pfizer Inc", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "persons", "value": "Kindler, Jeffrey B", "rank": 3, "major": "N"}, {"name": "subject", "value": "Appointments and Executive Changes", "rank": 4, "major": "N"}], "pub_date": "2010-12-06T02:39:37+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Duff Wilson", "person": [{"firstname": "Duff", "middlename": null, "lastname": "Wilson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/8fee1ca8-3f72-56a6-85ce-d8688ceeba8b", "word_count": 590, "uri": "nyt://article/8fee1ca8-3f72-56a6-85ce-d8688ceeba8b"}, {"abstract": "David Einhorn, the president of Greenlight Capital, tells CNBC he likes Sprint Nextel, Apple and Pfizer.", "web_url": "https://dealbook.nytimes.com/2010/12/06/where-einhorn-is-investing-now/", "snippet": "David Einhorn, the president of Greenlight Capital, tells CNBC he likes Sprint Nextel, Apple and Pfizer.", "lead_paragraph": "David Einhorn, president of Greenlight Capital, goes into detail with CNBC about his portfolio. Among the holdings: Sprint Nextel, Apple and Pfizer.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Where Einhorn Is Investing Now", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "persons", "value": "Einhorn, David", "rank": 1, "major": "N"}, {"name": "organizations", "value": "CNBC", "rank": 2, "major": "N"}], "pub_date": "2010-12-06T20:46:43+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/4326a5e3-c268-5f2e-a793-d79f4488d1f0", "word_count": 50, "uri": "nyt://article/4326a5e3-c268-5f2e-a793-d79f4488d1f0"}]